Company profile: Qualicaps
1.1 - Company Overview
Company description
- Provider of two-piece empty pharmaceutical capsules and processing equipment, including gelatin capsules for oral dosage forms and dry powder inhalers; plant-based hypromellose capsules suited to moisture-sensitive APIs; inhalation capsules with superior aerosolization; and capsule filling, band-sealing, and visual inspection machines for precision, integrity, and quality control.
Products and services
- Quali-V® hypromellose capsules: Low-moisture hypromellose (plant-based) capsules ideal for new oral drug developments, delivering physical and chemical stability suitable for moisture-sensitive APIs and consistent performance in oral applications
- Quali-GTM gelatin capsules: Industry-standard-compliant gelatin capsules for solid oral dosage forms and dry powder inhalers, available for oral and inhalation routes to meet pharmaceutical quality expectations
- Capsule filling machines: Industrial-grade machines that accurately fill capsules with various formulations, architected for precision and efficiency in the pharmaceutical manufacturing process
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Qualicaps
Jean Brown Research
HQ: United States
Website
- Description: Provider of clinical research site management services, conducting post-operative pain studies for pharmaceutical companies. With 30+ years of experience in pain management protocols, vaccine testing, and phase I-IV studies, JBR operates two facilities near Salt Lake City, Utah and trains staff in patient interaction to deliver accurate, detailed study results using proprietary training.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Jean Brown Research company profile →
Quay Pharma
HQ: Australia
Website
- Description: Provider of contract development, manufacturing and packaging services, with scientific expertise and flexible response to support projects and improve the chances of successful clinical trials. Independent and privately owned.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Quay Pharma company profile →
QPS
HQ: United States
Website
- Description: Provider of GLP/GCP-compliant contract research services spanning discovery, preclinical and clinical drug development, including neuropharmacology, DMPK, toxicology, bioanalysis, translational medicine, and clinical development support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full QPS company profile →
SFL
HQ: Switzerland
Website
- Description: Provider of integrated consultancy solutions to pharma, biotech and medtech companies for global and local activities, with in-house expertise across product life cycle functions including Regulatory Affairs & Regulatory Intelligence, Quality & Supply Chain, and Medical Writing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SFL company profile →
Oncodesign
HQ: France
Website
- Description: Provider of precision medicine-driven oncology preclinical CRO services and biopharmaceutical R&D, developing anticancer therapies and leveraging platforms such as Nanocyclix for selective kinase inhibitors and OncoSNIPER AI for resistant patient stratification. Pipeline includes OPM-101 (RIPK2, IBD), OPM-102 (RIPK2, inflammation-related tumors), and an LRRK2 program (Parkinson’s), plus the IMODI cluster for cancer models and microbiota studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Oncodesign company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Qualicaps
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Qualicaps
2.2 - Growth funds investing in similar companies to Qualicaps
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Qualicaps
4.2 - Public trading comparable groups for Qualicaps
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →